Answers are grounded in this paper and cite their sources.
Retrospective analysis shows combined immune markers predict pneumonia outcome in elderly, suggesting improved risk stratification.
BACKGROUND: The clinical course of influenza A virus (IAV) pneumonia in elderly patients is highly variable and strongly influenced by immunosenescence and dysregulated inflammation. Despite the prognostic relevance of inflammatory markers, reliably stratifying high-risk patients remains challenging. We investigated the combined potential of the systemic immune-inflammation index (SII) and the platelet-to-lymphocyte ratio (PLR) as a novel, accessible composite prognostic tool for this susceptible population. METHODS: A retrospective analysis was conducted on 160 patients aged ≥ 65 years with IAVP, who were divided into favorable prognosis (CURB-65 < 3, n = 71) and poor prognosis (CURB-65 ≥ 3, n = 89) groups based on their CURB-65 scores. RESULTS: The poor prognosis group exhibited significantly higher levels of white blood cells, neutrophils, C-reactive protein (CRP), interleukin-6 (IL-6), erythrocyte sedimentation rate (ESR), blood urea nitrogen (BUN), creatinine (Cr), PLR, and SII, as well as lower levels of prealbumin, albumin, total protein, and lymphocyte counts (all P < 0.05). CONCLUSION: Both PLR and SII are positively correlated with disease severity and serve as independent prognostic indicators in elderly IAVP patients. Their combination enhances the accuracy and generalizability of clinical risk stratification models.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: